Serbia Mattresses: Final Results of AD Admin Review
The Commerce Department has published the final results of the antidumping duty administrative review on mattresses from Serbia (Commerce case number A-801-002; CBP case number A-480-002). Commerce found the only company under review, Healthcare Europe DOO Ruma, made sales of subject merchandise to the U.S. at less than fair value during the period under review, and confirmed its preliminary finding of an AD rate of 42.09%. A 42.09% AD cash deposit rate for Healthcare Europe takes effect Oct. 9. Commerce will instruct CBP to liquidate entries from Healthcare Europe during the review period May 1, 2022, through April 30, 2023, at importer-specific rates.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
For exporters of subject merchandise that were not under review (i.e., all exporters of subject merchandise except Healthcare Europe), cash deposit rates remain at the level set in the most recent review of each respective company. If the exporter has never been assigned its own AD rate, but the manufacturer has, the rate assigned to the manufacturer applies. For merchandise manufactured and exported by companies that have never been assigned a cash deposit rate by Commerce, the all-others rate of 112.11% applies.
(The review period is 05/01/22 - 04/30/23. See Commerce's notice for more information, including the scope of the order, detailed cash deposit and assessment instructions, etc. See 2405310059 for a summary of the preliminary results of this AD administrative review.)